Furthermore, this study in vitro demonstrated that PAGln intervention induced ROS generation concomitant increased NOX and decreased SOD activity, CaMKII and RyR2 activation and apoptosis in mouse atrial myocytes, providing direct evidence for the adverse effects of PAGln in AF. This evidence concerns the gene CAMK2G and atrial fibrillation.